Australia releases overview of proposed IVD regulations
This article was originally published in RAJ Devices
Executive Summary
Australia’s Therapeutic Goods Administration has published an overview of the proposed new regulatory framework for in vitro diagnostic devices that it intends to introduce later this year1. Prior to the implementation of the new IVD framework, however, the Therapeutic Goods (Medical Devices) Regulations 2002 will have to be amended to include provision for IVDs. The TGA says that the regulations are currently being redrafted and when they are available, it will be organising information sessions for stakeholders.
You may also be interested in...
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.
Outlook Turns To Marketing Strategy After Scoring EU First For Ophthalmic Bevacizumab
Outlook Therapeutics’ intravitreally injected Lytenava has won the thumbs up from the European Medicines Agency. The company is assessing both direct commercialization of the product and partnering in Europe on a country-by-country basis.
EU CHMP Opinions And MAA Updates
This is an update of recommendations from the European Medicines Agency's Committee for Medicinal Products for Human Use on the authorization of new medicines in the EU, and updates on EU marketing authorization changes recommended by the CHMP.